Parenteral nutrition-associated metabolic bone disease

Journal of Parenteral and Enteral Nutrition

Volumn 26, Issue 5 SUPPL., 2002, Pages

  Seidner, Douglas L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE ATROPHY; BONE STRENGTH; CONFERENCE PAPER; HUMAN; METABOLIC BONE DISEASE; OSSIFICATION; OSTEOMALACIA; OSTEOPOROSIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; ALUMINUM OVERLOAD; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE PAIN; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); FRACTURE; HYPERCALCIURIA; METABOLIC ACIDOSIS; NONHUMAN; PATHOGENESIS; INCIDENCE; PATHOLOGY; REVIEW;

ACETIC ACID; AMINO ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CONJUGATED ESTROGEN; GLUCONATE CALCIUM; MAGNESIUM; MAGNESIUM SULFATE; PARATHYROID HORMONE; PHOSPHATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SODIUM; VITAMIN D;

BONE DISEASES, METABOLIC; HUMANS; INCIDENCE; OSTEOMALACIA; OSTEOPOROSIS; PARENTERAL NUTRITION;

EID: 0036720925     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710202600511     Document Type: Conference Paper

References (33)

1. Endocrinology
2. Bone marrow, cytokines, and bone remodeling
3. Metabolic bone disease in patients receiving long term total parenteral nutrition (TPN)
4. Bone disease associated with TPN
5. Bone disease in prolonged parenteral nutrition: Osteopenia without mineralization defect
6. Metabolic bone assessment in patients with inflammatory bowel disease
7. The management of hypercalcemia of malignancy
8. Small bowel resection associated urinary calcium loss in rats on long term TPN
9. A controlled study of bone mineral density in patients with inflammatory bowel disease
10. Multifactorial low remodeling bone disease during cyclic TPN
11. Role of sulfur-containing amino acids in protein-induced hypercalciuria in men
12. The effect of insulin on renal handling of sodium, potassium, calcium and phosphorous in man
13. Amino acid induced hypercalciuria in patients on TPN
14. Calcium and phosphorous metabolism during TPN
15. Reduction of TPN induced urinary calcium loss by increasing the phosphorous in the TPN prescription
16. Effects of phosphate administration on tubular calcium transport
17. Calciuretic effect of cyclic versus continuous TPN
18. Mineral loss in parenteral nutrition patients
19. A longitudinal study of calcium regulation in a nonhuman primate model of parenteral nutrition
20. Chronic acidosis in metabolic bone disease: Effective alkali on bone density and vitamin D metabolism
21. D-lactate and metabolic bone disease in patients receiving long term parenteral nutrition
22. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition
23. Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism
24. Aluminum in parenteral products: Medical perspective on large and small volume parenterals
25. Aluminum in parenteral nutrition solutions: Sources and possible alternatives
26. A possible role of vitamin D in the genesis of parenteral nutrition induced metabolic bone disease
27. Metabolic bone disease in a patient on long-term TPN: A case report with review of literature
28. The mechanisms of vitamin D toxicity
29. Increase in lumbar spine bone mineral content in patients on long term parenteral nutrition without vitamin D supplementation
30. Biochemical markers in the assessment of bone disease
31. Parenteral nutrition
32. The importance of urinary magnesium values in patients with gut failure
33. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis